Virtual Incision is on a mission to miniaturize robotic surgery, so more patients, surgeons, and healthcare facilities can have access to its benefits every day.
Virtual Incision
1501 Old Cheney Rd Lincoln, Nebraska, United States
January 31, 2024
Virtual Incision sent its spaceMIRA surgical robot to the ISS to test long-range remote capabilities on surgical devices in hopes of greater utilization on Earth in under-served communities.
February 24, 2023
Virtual Incision claimed that it was the first robot-assisted surgical developer to complete a study to support a De Novo request for MIRA to conduct bowel resection procedures.
August 10, 2022
Virtual Incision said its MIRA miniaturized robot-assisted surgical device will demonstrate the potential for greater access to surgical care on Earth and beyond.
April 19, 2022
Virtual Incision announced that the FDA has granted it an Investigational Device Exemption to complete research on how its robot-assisted surgery platform can aid bowel resection procedures.
November 30, 2021
The MIRA surgical platform, which Virtual Incision says is the first miniaturized robot of its kind, is currently in clinical studies as the company gets financing for commercialization.
August 16, 2021
On its path to commercialization, Virtual Incision has participated in the first procedure using its MIRA miniature robotic surgical system under an FDA IDE exemption.